Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays
2008

New Tests for Angiopoietins in Critically Ill Patients

Sample size: 124 publication Evidence: moderate

Author Information

Author(s): Lukasz Alexander, Hellpap Julian, Horn Rüdiger, Kielstein Jan T, David Sascha, Haller Hermann, Kümpers Philipp

Primary Institution: Hannover Medical School

Hypothesis

Can circulating Ang-1 and Ang-2 serve as reliable biomarkers for endothelial integrity in critically ill patients?

Conclusion

Ang-1 and Ang-2 might serve as a novel class of biomarker in critically ill patients.

Supporting Evidence

  • Ang-1 and Ang-2 concentrations correlated with severity of illness in critically ill patients.
  • The assays had detection limits of 0.12 ng/ml for Ang-1 and 0.2 ng/ml for Ang-2.
  • Ang-1 and Ang-2 concentrations were stable for 24 hours and resistant to freeze-thaw cycles.

Takeaway

Doctors can use new tests to measure two important proteins, Ang-1 and Ang-2, in sick patients to see how well their blood vessels are working.

Methodology

Developed sandwich immunoassays for Ang-1 and Ang-2, tested on 30 healthy controls and 94 critically ill patients.

Limitations

The study did not focus on the diagnostic or prognostic value of circulating Ang-1 and Ang-2.

Participant Demographics

94 Caucasian ICU patients, 56 males and 48 females, aged 59 years (21 to 69).

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc6966

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication